Exemestane ZPHC — 25 mg × 100 tablets
Exemestane (Aromasin®) — irreversible steroidal AI 100 film-coated tablets × 25 mg Mechanism: permanently deactivates aromatase, lowering estrogen by ≈ 85 % and boosting endogenous testosterone. Research uses: post-cycle therapy, estrogen-dependent breast cancer models, mitigation of gynecomastia & water retention. Dose guide (research): 12.5 mg EOD for mild E2 control · 25 mg EOD during high-aromatase cycles · 25 mg daily × 2 weeks in PCT protocols. Lipid support: monitor HDL/LDL; consider omeg
Exemestane (ZPHC) is an irreversible steroidal aromatase inhibitor supplied as 100 tablets of 25mg each. It permanently deactivates the aromatase enzyme, lowering circulating estrogen by roughly 85% while helping to boost endogenous testosterone.
Widely used during and after anabolic steroid cycles, Exemestane helps control estrogen-related side effects such as water retention and gynecomastia, making it a common on-cycle and PCT-support aromatase inhibitor.
Key Benefits
- Irreversibly suppresses aromatase, providing durable estrogen control
- Helps prevent and mitigate gynecomastia and water retention
- Supports a rise in endogenous testosterone by lowering estrogenic feedback
- Useful both during high-aromatizing cycles and in post-cycle protocols
Bewertungen (0)
Noch keine Bewertungen.
